Acute Kidney Injury Medication Adjustment

At suspected or confirmed AKI, reconcile every prescribed, over-the-counter, inpatient, contrast-related, and recently discontinued medication against baseline creatinine, current creatinine trajectory, urine output, blood pressure, volume status, and the timing of acute illness. Stop or avoid nephrotoxic drugs and review drugs that alter renal hemodynamics or require renal dose adjustment. Nephrotoxins contribute to an estimated 20% to 30% of AKI cases. BMJBMJAcute kidney injury - Management recommendations | BMJ Best Practice

Do not equate all creatinine rises after medication exposure with intrinsic drug nephrotoxicity. A rise during vomiting, diarrhea, sepsis, perioperative hypotension, or heart failure may reflect reduced effective kidney perfusion compounded by NSAIDs, ACE inhibitors, ARBs, or diuretics. The immediate decision is to restore or support hemodynamics, identify the precipitating illness, and reassess whether each agent remains appropriate in the current physiologic state. BMJ+2BMJAcute kidney injury - Management recommendations | BMJ Best PracticeBMJWhat are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysisPubMedAcute Kidney Injury: From Diagnosis to Prevention and Treatment Strategies - PMC

Measure and trend serum creatinine in adults with acute illness who have CKD, oliguria below 0.5 mL/kg/hour, hypovolemia, sepsis, recent iodinated contrast exposure, obstructive symptoms, or recent exposure to NSAIDs, aminoglycosides, ACE inhibitors, ARBs, or diuretics. CKD with eGFR below 60 mL/min/1.73 m² confers particular AKI risk. nice org uk+1nice org uk[PDF] Acute kidney injury - NICEnice org uk[PDF] Acute kidney injury: prevention, detection and management | NICE

Stop NSAIDs in established AKI unless an exceptional competing indication outweighs renal risk. NSAIDs can exacerbate AKI during hypovolemia and are associated with interstitial nephritis, which can itself cause AKI or worsen preexisting injury. Their risk is amplified by concurrent renin-angiotensin system blockade and diuretics. PubMed+1PubMedAcute Kidney Injury - StatPearls - NCBI Bookshelf - NIHnice org uk[PDF] Acute kidney injury: prevention, detection and management | NICE

ACE inhibitors and ARBs require a contextual decision rather than automatic permanent discontinuation. During AKI with hypotension, hypovolemia, or impaired renal autoregulation, temporarily withhold or reassess the agent while correcting the precipitating physiology. These drugs are specifically identified among medications that can cause or exacerbate AKI, especially in hypovolemic patients. BMJ+2BMJAcute kidney injury - Management recommendations | BMJ Best PracticeBMJWhat are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysisnice org uk[PDF] Acute kidney injury: prevention, detection and management | NICE

Diuretics should be evaluated against the patient’s effective circulating volume and congestion rather than discontinued reflexively. In a patient with AKI plus hypovolemia or hypotension, holding the diuretic is appropriate while volume status and blood pressure are optimized; continued diuretic exposure can also compound NSAID and renin-angiotensin system inhibitor risk. BMJ+2BMJAcute kidney injury - Management recommendations | BMJ Best PracticeBMJWhat are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysisScienceDirectCombined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin–angiotensin system inhibitors in the community increases the risk of acute kidney injury - ScienceDirect

Aminoglycosides are recognized nephrotoxic exposures in AKI risk assessment and should be avoided when a clinically effective non-nephrotoxic alternative is available. When an aminoglycoside is necessary, dose selection cannot rely on a static renal-function estimate during fluctuating AKI; incorporate severity of infection, changing renal clearance, and therapeutic drug monitoring where available. BMJ+3BMJAcute kidney injury - Management recommendations | BMJ Best PracticeNatureAntibiotic dosing in critically ill patients with acute kidney injury | Nature Reviews NephrologyScienceDirectTherapeutic Drug Monitoring - an overviewnice org uk[PDF] Acute kidney injury: prevention, detection and management | NICE

For patients with CKD stage G3 or higher, defined as eGFR below 60 mL/min/1.73 m², KDIGO guidance supports avoiding nephrotoxic medications or reducing their dose. In AKI superimposed on CKD, use the best current estimate of kidney function for dose adjustment, but recognize that rapidly changing creatinine makes any single estimate imprecise. PubMed+2PubMedKDIGO 2024 clinical practice guideline on evaluation and ... - PMCPubMedUse of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine carePubMedAcute Kidney Injury - StatPearls - NCBI Bookshelf - NIH

Adjust medication doses for renal function in all patients at risk for or with established AKI, but reassess whenever the creatinine trajectory, urine output, fluid balance, hemodynamics, or renal replacement therapy changes. KDIGO therapeutic measures include medication-dose adjustment, hemodynamic monitoring, fluid balance control, discontinuation of nephrotoxins, and avoidance of iodinated contrast where possible. PubMedPubMedAdherence to guidelines for management of acute kidney injury

Creatinine-based renal estimates can lag behind abrupt changes in filtration. In critically ill AKI, expanded volume of distribution, altered clearance, and renal replacement therapy create substantial pharmacokinetic variability; dosing should therefore incorporate the clinical indication, severity of infection, renal and volume trajectory, modality of renal support, and drug-specific pharmacodynamics rather than a published renal-dose table alone. Nature+2NatureAntibiotic dosing in critically ill patients with acute kidney injury | Nature Reviews NephrologyNatureAcute kidney injury | Nature Reviews Nephrologykhi asn-onlineKidney Health Initiative (KHI) | Pharmacokinetics in Patients Receiving Continuous Renal Replacement Therapy

For life-threatening infection, avoid underexposure caused by automatic reduction of initial antimicrobial doses solely because creatinine is elevated. Critically ill patients with AKI may require increased antibiotic doses despite reduced renal clearance, particularly for serious infections. After initial therapy, use serial clinical assessment and therapeutic drug monitoring when available to individualize exposure. Nature+1NatureAntibiotic dosing in critically ill patients with acute kidney injury | Nature Reviews NephrologyScienceDirectTherapeutic Drug Monitoring - an overview

Use the medication timeline to prioritize mechanisms, but do not diagnose prerenal, intrinsic, or postrenal AKI from fractional excretion of sodium, fractional excretion of urea, or urine osmolality alone. These indices are altered by commonly used drugs, including diuretics, and no single marker reliably distinguishes AKI causes in isolation. Integrate volume examination, hemodynamics, urinalysis, obstruction history, creatinine trend, and response to targeted interventions. PubMedPubMedAcute Kidney Injury - StatPearls - NCBI Bookshelf - NIH

Evaluate for obstruction when symptoms or history suggest urologic obstruction or a condition predisposing to obstruction, because medication withholding will not correct a postrenal process. AKI risk assessment should also actively identify sepsis, hypovolemia, contrast exposure, and nephritic features such as edema or hematuria, each of which changes the next diagnostic and therapeutic action. nice org uk+1nice org uk[PDF] Acute kidney injury - NICEnice org uk[PDF] Acute kidney injury: prevention, detection and management | NICE

Discuss AKI management with nephrology as soon as possible and within 24 hours when there is stage 3 AKI, inadequate response to initial treatment, AKI complications, renal transplantation, or another high-risk clinical context. This should occur alongside—not after—medication reconciliation and hemodynamic optimization. nice org uk+1nice org uk[PDF] Acute kidney injury: prevention, detection and management | NICEnice org uk[PDF] National Institute for Health and Care Excellence - NICE

After AKI improves, perform a second medication reconciliation rather than automatically resuming the preadmission list. Reassess the original indication for ACE inhibitor, ARB, diuretic, and any nephrotoxic medication; confirm recovery of blood pressure, volume status, urine output, and kidney function before reintroducing an agent that was withheld for hemodynamic AKI. BMJ+2BMJAcute kidney injury - Management recommendations | BMJ Best PracticePubMedAcute Kidney Injury: From Diagnosis to Prevention and Treatment Strategies - PMCPubMedAcute Kidney Injury - StatPearls - NCBI Bookshelf - NIH

Arrange follow-up at approximately 3 months after AKI to assess kidney recovery and progression to CKD or progressive CKD. The follow-up evaluation should include kidney function, proteinuria, medication reconciliation, patient education on nephrotoxin avoidance, and CKD-progression prevention strategies when kidney disease persists. PubMedPubMedAcute Kidney Injury: From Diagnosis to Prevention and Treatment Strategies - PMC

For patients with CKD or prior AKI, provide explicit anticipatory counseling about dehydration and nephrotoxin exposure, especially NSAID use. This is most consequential when patients also take ACE inhibitors, ARBs, or diuretics or have eGFR below 60 mL/min/1.73 m². ScienceDirect+2ScienceDirectCombined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin–angiotensin system inhibitors in the community increases the risk of acute kidney injury - ScienceDirectPubMedUse of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine carePubMedAcute Kidney Injury - StatPearls - NCBI Bookshelf - NIH